Lyra Therapeutics Inc (LYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 271 | 14 | 0 | 0 | 0 |
| Gross Profit | 271 | 14 | N/A | N/A | N/A |
| Operating Expenses | 13,909 | 11,095 | 11,065 | 7,831 | 7,053 |
| Operating Income | -13,638 | -11,081 | -11,065 | -7,831 | -7,053 |
| Other Income | 21 | 26 | 26 | 29 | 32 |
| Pre-tax Income | -13,617 | -11,055 | -11,039 | -7,802 | -7,021 |
| Net Income Continuous | -13,617 | -11,055 | -11,039 | -7,802 | -7,021 |
| Net Income | $-13,617 | $-11,055 | $-11,039 | $-7,802 | $-7,021 |
| EPS Basic Total Ops | -52.50 | -42.50 | -42.50 | -30.00 | 858.00 |
| EPS Basic Continuous Ops | -52.41 | -42.51 | -42.48 | -30.13 | 839.47 |
| EPS Diluted Total Ops | -52.50 | -42.50 | -42.50 | -30.00 | 858.00 |
| EPS Diluted Continuous Ops | -52.41 | -42.51 | -42.48 | -30.13 | 839.47 |
| EBITDA(a) | $-13,360 | $-10,731 | $-10,762 | $-7,761 | $-7,012 |